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Fibroblasts from individuals with Down syndrome (DS; trisomv 21) exhibit increased inositol uptake. Here wc examine the relationship bcwecn 
this increase in uprake and mass levels of free inositol and ino&ol l.4,5-trisphosphalc (II”,) in DS fibroblasis. WC report that human fibroblasts 
contain high lcvcls or rrec inoshol which are not significantly alTcctcd by the incrcasc in inositol uptake associated with DS. In addition. incrcascd 
uptake is accompanied by incrcascd elllux oT radiolabellcd inositol liom DS cells. Ncithcr basal nor bradykinin-stimulated IP> !cvels in DS cells 
dil%r significantly from normal values. This work highlights the uschdncss or the DS cell in uncovering rhc role of lransporl across the plasma 
mcmbranc in cellular inoshol homcoslasis. 
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I. INTRODUCTlON plasma membrane plays a vital role. Catabolism of ino- 
sitol is apparently limited to the kidney [5]. 
Trisomy of all or part of chromosome 21 produces 
Down syndrome (DS), a major cause of mental retarda- 
tion. We recently reported that skin fibroblasts from 
individuals with DS exhibit an increased rate of inositol 
accumulation due to a specific increase in the maximal 
velocity of high-affinity, Na’-dependent inositol trans- 
port coincident with trisomy of the distal segment of the 
long arm of chromosome 21 [I]. These findings led us 
to suggest he possibility tha? a!tered regulation of high- 
affinity inositol transport may be a significant factor in 
the pathophysiology of DS. This possibility is 
supported by studies showing the expression of a similar 
high-affinity inositol transport system by many other 
tissues [2] including fetal brain [3]. However, the patho- 
physiologic significance of enhanced inositol uptake is 
ultimately dependent on how the levels and turnover of 
inositol and its metabolites are affected in the various 
cells and tissues of the DS individual. 
Cells maintain high levels of free inositol by drawing 
from three potential sources: uptake from the media, de 
novo synthesis from glucose 6-phosphate, and recycling 
of inositol phosphates. The relative importance of each 
source is a point of controversy and certainly varies 
between different cell types. But the fact that the sur- 
vival of most cells is dependent on an external supply 
of inositol [4] is evidence that transport across the 
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Changes in inositol homeostasis are associated viith 
important functional and developmental consequences 
in certain cell types [6,7]. Neural cells in particular ex- 
hibit sensitivity to abnormally low or high inositol 
levels. For examp!e, reduced inositol uptake by periph- 
eral nerves from diabetic animals is accompanied by 
decreases in inositol.content and inositol lipid metabo- 
lism, changes that are linked to deficits in Na’,K+-ATP- 
ase activity and conduction velocity [8]. In the brain, 
lowered inositol levels brought on by LiCl treatment are 
thought to underlie the ability of this drug to modulate 
neural activity [9]. Studies of both experimental animals 
and human subjects show that abnormally high inositol 
levels also impair nerve function. F#,r example, induc- 
tion of hyperinositolemia in rats results in decreased 
nerve conduction velocity [lo]. Similarly, in patients 
with chronic renal failure elevation of plasma inosito! 
is correlated with impaired nerve conduction [I I]. More 
subtle clectrophysiological effects have been reported to 
follow oral administration of inositol to patients [I 2,131. 
The particular sensitivity of neural cells to inositol is 
also suggested by a study of cultured dorsal root gan- 
glion cells in which morphologic abnormalities were 
observed following exposure to increasing concentra- 
tions of inositol [l4]. Not all cell types, however, are 
similarly sensitive to altered inositol homcostasis. For 
example, renal cpithelial cells increase high-affinity ino- 
sitol uptake and intracellular inositol content as an 
adaptive response to osmotic stress [15]. This response 
is not associated with apparent changes in inosilol lipid 
metabolism or signal transduction [l6]. lnositol homeo- 
Pdtlished hJ1 E/w ricr Scictrre Puh/i.dier.~ B. I/. 43 
Volume 295. number 12.3 FEBS LETTERS December I99 I 
stasis also appears to be it relevant factor in hematologic 
differentiation where differential expression of inositol 
transport is associated with changes in intracellular 
levels of free inositol and higher inositol phosphates 
characteristic of maturation down particular develop- 
mental pathways [Ii-191. 
In this report we examine the relationship between 
enhanced inositol uptake and the overall ~nass levels of 
inositol in DS fibroblasts. In addition. receptor-mediat- 
ed signal transduction via the inositol lipid cycle is 
evaluated through mass determinations of inositol 
I .4.5-trisphosphate (IP,). Our results indicate that not- 
withstanding enhanced inositol uptake, DS fibroblasts 
maintain near normal levels of inosi!ol and IP,. 
2. MATERIALS AND METHODS 
Human skin librobhw wrc obtained frcm the Human Gcnctic 
Idutant Cell RcposiIory. Camden. NJ (GM02767B. G&104592. 
GMO-16lG. GMO4614. GM03348B. Gh13440. G~lO0408B. GM05659 
nnd GM0288A) and I’rom the lilborntory of Diane Arthur. University 
of Minnesota (PLESSAL7324). Thcsc cells conIpriscd five Irisomy 21 
ond fwc nornwl diploid sIrilins. Cells WCIC grown in Dulbccco’s 
modilicd Eagle’s Medium (DVEM. Gibco) supplemcntcd with 5% 
1‘ctal citll‘scrum and 5% newborn calf sawn in a humidified 5% CO1 
iilniosphcrc. 
Cells wcrc swdcd inIo 24-wll plates aI a density ol’25 000 cclls~wcll 
and grown until nwr COII~~UCIIC~ (2-3 days). The uptake ol’ ,,t~w- 
[‘H]inositol (80 CiWnmol. AnIcrsham) during 1 2 II incubations was 
detcrmincd ;IS dcscribud [I] csccpt that DMEM comaining IO mhl 
HEPES (pH 7.4) was used as IIIC incubaion medium. The final inositol 
concentration ol’ this medium is -40 ,uM. To assess cl’flux ol’ inositol. 
cells wcrc prclabcllcd Ibr 2 h ils ilbovc IIICII \\asllcd with ph~~philt~- 
bulYcrcd saline (PBS) alid incub;tIcd in unlab:llcd media. 37°C. AI 111~ 
indicated times. this mrdium WHS removed by aspiration and the IX- 
dioactivhy rcmnining in 111~ cells counted. Th: identity ol’thc r;tdiow 
tivity nppcaring in IIIC cfilux medium was cxamincd using Ihin-Inycr 
chromatography on silica gel plilIcS (WhaInI;m) dcvclopcd in rr-pro- 
p~tnol~ctliy!acctatc~~~~~t~r/25~~ ammonia 15:1:3: I ). and viswlizcd by 
illltO~ildiO~r;lpll~. 
Intrnccllul;ir I’rcc inositol was mcasurcd in pcrchloric acid csIracIs 
using a novcl adaption o~prcviously dcscribcd methods based on the 
cnzymaIic oxid;lIion or inosiIol [20-221. Conllucnt libroblast mono- 
layers in 25 cm’ I!asks (Costilr) wcrc quickly \wshcd 3 times wiIh I2 
ml or ice-cold PBS. Then 600 nil PBS/IO mM 1-I EPESi0.00058 Phenol 
red WIS added followed by I?OpI or 10% pcrchloric acid. Flasks wcrc 
kcp\ on ice I’or 30 min with inturmittcnt rocking. The supcrnamt (720 
~1) was rumovcd to phwic tubes and c;trclillly ncutralizcd ~4111 -I 20~1 
I.5 M KOH/GO mM HEPES. Prccipitatcd pcrchloratc wits wcrc rc- 
moved by ccntrifuufation for IO min at 2000 xx. 4°C. As iI prccaution- 
iiry step. 111~ supcrniII;tnt \Ws treated wiih 50 ~1 glucose oxidnsc 
rcagcnl (?O U/ml gl::a~c osidasc, 350 Uim! c:!t:tI~sc in PBS) IO 
climinatc he poIcnIi;ll inTcrcncc by .glucosc [Zl]. Tubes wcrc incubated 
ill 37’C I’or 90 min, and II~CII heated iII IOO’C for 3 min IO slop IIIC 
rcnction. Supcrn;lI;mIs wrc stored ~II -70°C. 
To IO0 ~1 ol’samplc in triplicate was added 50 ,ul ol’distillcd wittcr 
iind 50 yl ol’ii I’rcshly prcpilrcd mixiurc or25 mM NAD in I M K’ 
phosph~tc, pH 9: 20 nIM I’crrozinc (Sigma) in4 mM FcCI,; and 63jr.M 
phcniwinc mcIhosulW. The reaction was sIiIrtcd by ihc addition or 
5 niU 01‘ +winosiIol dchydrogcnasc (Signw) in IO ~1 PBS. SiImplCs 
wcrc vorlexcd and incub;IIcd iIt 37°C ror2 h.Thc rwction was stopped 
by IIIL‘ addition or IO ~1 of IO% pcrchloric acid. This uwtmcnt dots 
not slTcct the colored rcrrous-rcrrozinc complex [23] but climinatcs 
;III~ intcrrercncc or phenol red i~bsorb:Incc. Supcrmnants wc’rc trans- 
rcrwd to 96-well plates and the absorbance at 560 nnl was dctcrmincd 
on ;I plate-rcndcr. Samples wcrc read against the nbsorbancc or ino- 
shol standards (0.5-10 nM) proccsscd in the same WV. When cellular 
WIllpIes wcrc spiked with various known amounts orinositol prior 10 
pcrchloric acid c:iIl;lctiotl. rccovcry avcragcd 91% ? 4 ()1=5). 
Conllucnt cells in 24-well plates wcrc incubaIcd overnight in 
DblEM conI;\ining 1% newborn calr scram then cxposcd to IO mM 
LiCl ror IO min prior IO stimulation. Cells wcrc wshcd and trcatcd 
wilil 250 ,ul ol’D>lEWIO rnhl HEPES containing vwious conccntra- 
tions of bradykinin. Incubations at 37°C wcrc tcrniinatcd by Ihc 
:iddiIiott of IO% pcrchloric acid and 7 a cu!rnlizcd as above. IP, in ~hc 
supcrnatants \vitS mcasurcd by a radioroccptor binding assay [24] 
tnilizing a spccilic IP; binding protein Tram bovine adrenal micro- 
SOI~CS and [‘H]IP, (Amcrsham). 
3. RESULTS 
To examine the relationship between enhanced ino- 
sitol uptake by DS cells and cellular inositol content, 
these two parameters were measured concomitantly on 
replicate plating of the same cells (Fig. I ). III agreement 
with previous results [I] DS fibroblasts showed ;I 
dramatic (greater than 3-fold) increase in rH]inositol 
accumulation. Surprisingly, however, the bulk free ino- 
sitol content of DS fibroblasts was not significantly dif- 
crent from normals. These determinations of libroblast 
inositol content are similar to previously determined 
levels in cultured endothelial [25] and epithelial cells 
[15.16]. However, other cell types. for example those of 
neural [26] or myeloid [I71 origin contain nn.tch lower 
levels of inositol. 
To investigate potential nicchatiisnis which might 
contribute to the ability of DS llbroblasts to maintain 
normal levels of inositol under conditions of enhanced 
uptake, we examined the efflux of [“Hlinositol from fi- 
broblasts prelabellcd for 2 h. DS cells showed a greatly 
increased initial rate of [‘M]inositol cfflux relative to 
that of normal diploid cells (Fig. 2A). For both DS and 
normal cells, the concentration of inositol in the efflux 
nledium had little effect on the rate of elnux (Fig. 28) 
The radioactivity appearing in the CIYUX mediun? 
CONTENT UPTAKE 
Fif. I. Inoshol content or DS and normal diploid fibroblssis ilnd iIs 
IrkiIionship IO inosiIol UpIilkC. ViIltICS w.z 11x n:c;m 5 SE or I’our 
?ep;Iratc cxpcriacms (prrrormcd in triplicate) pairing DS and norm;ll 
cclls. *P < 0.01 compared IO nornI;Il uptake. pnircd SIudcnI’s r-test. 
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Fig. 2. El’llux or [?H]inosilol from DS and normal diploid cells. (A) 
Time course of clIux I’ollowine _ 2 h pulse wilh [‘Hlinosilol. Dana arc 
rhz means f SE of 3 scp;lratc cxpcrimcnts. (B) Eli&t o~cxw~cllular 
inositol on cfllux. Cells wrc prclabcllcd as abovc lhcn incubalcd in 
inositol-free DMEM supplcmcn~cd with the indicalcd conccmrations 
or inositol or its isomer scyllhol. Rcsuhs arc csprcsscd as IIIC pcrccnt 
oftlic inilial radiodclivilv remaining in UK! cells alicr 3 Ii. D;IKI arc the 
mean ofduplicato dcwr&ations from a sinclc cxpcrimcm rcprcscnm- 
live 0r iwo similar cxpcrimcnls. 
migrated with [“Hlinositol standards during thin-layer 
chromatography (data not shown). 
To investigate a potential relationship between en- 
hanced inositol uptake by DS cells and transmemhranc 
signalhng via iPJ production, mass levels of IPs were 
measured in unstimulated and bradykinin-stimulated 
ceiis. Time courses of iPX production in ceiis exposed to 
I-,M bradykinin showed peak stimulation between 5 
and IO s for both DS and normal cells (Fig. 3A). Whca 
IPs levels and inositol uptake were measured together 
in paired sets of DS and normal cells, neither basal nor 
bradykinin-stimulated IP3 levels of DS cells were signif- 
icantly different from those of normal cells (Fig. 3B)? 
although the difference in uptake by DS and normal 
cells was more than 3-fold (Fig. 3C). 
4. DISCUSSION 
The present results demonstrate that increased ino- 
sitol uptake by DS fibroblasts is not associated with 
significant changes in overall mass levels of free inositol 
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Fig. 3. IPI conwu 01~ DS and normal diploid fibroblasls and ils 
relationship IO inosilol uplakc. (A) Time course of IIJJ production in 
rcsponsc IO I )rM bradykinin. Dma arc IIIC means of duplicate dcrcr- 
minalions irom a single cxpcrimcnl. (B) !vlcan basal and bradykinin- 
stimula[cd (8 s) IP1 lcvcls rrom 5 cxpcriments. (C) Inoshol uptake by 
cells assayed for IP1 conlen (panel B). ‘P d 0.02. paired Student’s 
I-lCS1. 
or its pivotal second messenger metabolite lP1. Addi- 
tional fiadings showing that tllc cfflux of [3H]inositol 
from DS cells is also increased offer an attractive cx- 
planation of how DS fibroblasts arc able to maintain 
normal inositol levels under conditions of cnhanccd 
uptake. However, without knowledge of the specific ac- 
tivity or actual mass levels of inositol exitting the cell it 
is difficult to judge with certainty the importance of this 
pathway. Thus, the mechanism and regulation of ino- 
sitol efllux by DS cells deserve further investigation. II 
is also important to consider that transport across the 
plasma membrane may be a quantitatively minor 
(though not necessarily inconscqucntial) source of total 
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fibroblast inositol. and that this too may contribute to 
the lack of any detectable change in inositol levels in DS 
cells. The relatively high levels of inositol reported here 
for fibroblasts are consistent wit!1 this view. 
In contrast to our findings with human skin fi- 
broblasts, a close association between inositol transport 
activity and cellular inositol levels does exist in certain 
cell types. This has been demonstrated, for example. in 
cultured neuroblastoma [26], promyeloid [ 171, and renal 
cell lines ;!5]. However, studies of cultured lens epi- 
thelial cells [2i’] and in vitro preparations of aortic wall 
[28] show that in other tissues, like in F.brcXasts. ino- 
sitol uptake can be modulated without measurable 
changes in total inositol content. Clearly, there are im- 
portant differences in the mechanisms through which 
different cell types maintain free inositol levels. These 
differences presumably reflect differential expression of 
inositol uptake, efflux. synthesis, and metabolism, as 
well as iifferences in the homeostatic mechanisms 
which regulate these processes. 
The present results do not rule out the possibility that 
the levels or turnover of some small, discrete pool of 
inositol metabolites in the DS cell may be affected. 
Certainly the flux of a nutrient through the cell (in- 
dependent of changes in mass levels) can itself be ratc- 
limiting for metabolism [29]. Accordingly, our previous 
results have shown that enhanced uptake by DS cells is 
accompanied by an increased incorporation of [“Hlino- 
sitol into phospholipid [I]. Simmons and Winegrad 
[28,30] have demonstrated the existence of a discrete, 
rapidly turning over pool of phosphatidyl inositol in the 
rabbit aortic wall which is critically dependent on ino- 
sitol transport. In this system, inhibition of normal ino- 
sitol uptake results in impared N’,K’-A’i‘Pase activity 
through inhibition of a specific fraction of phosphatidyl 
inositol synthesis. These changes occur in the absence 
of changes in total tissue inositol. While the present 
study does not address the possibility that enhanced 
. inositol uptake may influence this or other novel 
pathways of inositol metabolism in the DS fibroblast, 
it does coIlfirm that any such influences, if present, 
operate apart from any significant effect on the best- 
characterized aspect of inositide metabolism, namely 
signal transduction via phosphatidylinositol 4,5-b& 
phosphate jlydrolysis to IP3. 
At present we can only speculate as to the role of 
inositol homeostasis in DS. Further studies examining 
the transport, levels, and metabolism of inositol in other 
DS tissues arc required. Such studies must bear in mind 
potential heterogeneity in the expression of transporters 
and other mechanisms regulating inositol levels in dif- 
ferent tissues. It is noteworthy in this regard that neural 
and hematopoietic tissues, where the functional and de- 
velopmental correlates of altered inositol uptake appear 
most pronounced, are the very tissues whidt exhibit the 
most significant pathological effects of trisomy 2 I [3 I]. 
Thus we speculate that some imbalance of inositol me- 
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tabolism may be related to the altered neural membrane 
properties [32,33] or the unusual prevalence of myelo- 
proliferative disorders [34] which are characteristic of 
these tissues in DS. However, we are aware of no 
reports of inositol metabolism in any DS tissue or cell 
type other than skin fibroblasts. Weighing the patho- 
physiological significance of enhanced inositol uptake 
in DS will also require a clearer understanding of the 
role of transport in inositol homeostasis [6]. Even on the 
cellular level, while it is clear that changes in inositol 
transport influence plasma membratre properties in 
certain cell types, the relationship of transport to the 
complex regulatory network of inositol metabolites is 
only beginning to be understood [30,35,36]. At the very 
least, further studies of inositol metabolism in DS 
should offer new insights into these problems in cellular 
physiology. Along with such insights may come irn- 
portant clues to the pathophysiology of DS. 
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